BioTuesdays

Category - Developments

Titan Pharmaceuticals Logo

Fortune hails Titan’s ProNeura technology

Fortune.com has featured Titan Pharmaceuticals (NASDAQ:TTNP) and its ProNeura technology, calling it a “formidable new class of pharmaceutical implants.” The article said Titan’s Probuphine implant for the treatment of...

Stryker to acquire Novadaq Technologies

Stryker (NYSE:SYK) has agreed to acquire Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) for $11.75 a share, implying a total equity value of approximately $701-million. The transaction price represents a premium of...

3D Signatures

3DS advances Hodgkin’s lymphoma test

The clinical trial component of 3D Signatures’ (OTCQB:TDSGF; TSXV:DXD; FSE:3D0) Hodgkin’s lymphoma test (Telo-HL) validation program is under way. This process is referred to as Stage 3 of the validation program...

Blue Spark Technologies

Blue Spark gets U.S. patent notice for TempTraq

The U.S. Patent and Trademark Office issued a Notice of Allowance for closely held Blue Spark Technologies’ patent application referred to as, “body temperature logging patch,” or its brand name, TempTraq. The wearable...